Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132306) titled 'Study on the mechanism of vitamin D in improving autistic behavior by inhibiting TPH1 transcription' on Sept. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Second Provincial General Hospital
Condition:
Autism Spectrum Disorder
Intervention:
Group A (Placebo):Received conventional rehabilitation therapy plus an oral placebo (sugar pill, once daily, two pills per dose).
Group B (Low-dose Vitamin D):Received conventional rehabilitation therapy plus 800 IU/day of vitamin D drops.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-17
...